MyFinsight
Home
Blog
About
Back
Cash Flow
REVELATION BIOSCIENCES, INC. (REVBW)
REVELATION BIOSCIENCES, INC. (REVBW)
source: myfinsight.com
Net increase
(decrease) in cash and cash...
-$2,630,623
(-98.52%↓ Y/Y)
Stock-based compensation
expense
$401,417
(78.94%↑ Y/Y)
Accrued expenses
$291,855
(175.19%↑ Y/Y)
Accounts payable
$136,692
(201.93%↑ Y/Y)
Non-cash lease expense
$56,146
Depreciation expense
$8,313
(-42.43%↓ Y/Y)
Net cash used in
operating activities
-$2,557,193
(45.75%↑ Y/Y)
Net cash used in
investing activities
-$39,628
Net cash provided by
financing activities
-$33,802
(-101.00%↓ Y/Y)
Canceled cashflow
$894,423
Net loss
-$3,323,384
(26.07%↑ Y/Y)
Purchase of property and
equipment
$39,628
Proceeds from warrant
inducement exercises, net
-$33,802
Prepaid expenses and
other current assets
$109,104
(-8.58%↓ Y/Y)
Operating lease liability
-$19,128
Back